Cargando…
Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection
Chronic hepatitis C1 is a common cause of liver disease worldwide. It is a slow and progressive condition which can lead to decompensated cirrhosis and hepatocellular carcinoma. Hepatitis C virus1 impairs quality of life (QOL) even in the absence of chronic liver disease, but its relative silent nat...
Autores principales: | Jafferbhoy, H, Gashau, W, Dillon, JF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169967/ https://www.ncbi.nlm.nih.gov/pubmed/21935317 |
Ejemplares similares
-
Coordination, Cost, and Changing Epidemiology—Considerations in the Hepatitis C Care Cascade
por: Yang, Nancy, et al.
Publicado: (2021) -
Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
por: Leleu, H, et al.
Publicado: (2015) -
Insomnia - treatment pathways, costs and quality of life
por: Scott, Guy W, et al.
Publicado: (2011) -
Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022) -
Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)